Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)

BACKGROUND: Pulmonary Arterial Hypertension (PAH) carries a poor prognosis in both adult and pediatric patients. It is a life-threatening condition in newborns. Current recommendations advocate the use of targeted monotherapy as a first-line approach for the treatment of Persistent Pulmonary Hyperte...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijay Kumar, J.R., Natraj Setty, H.S., Jayaranganath, M., Manjunath, C.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Akadémiai Kiadó 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467385/
https://www.ncbi.nlm.nih.gov/pubmed/36343291
http://dx.doi.org/10.1556/1646.2020.00004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467385/
https://www.ncbi.nlm.nih.gov/pubmed/36343291
http://dx.doi.org/10.1556/1646.2020.00004

Ejemplares similares